Abstract
"Double-Burden of Disease" or the "Epidemiological Transition" is a newly described insidiously growing global phenomenon, however, posing a special challenge to developing countries. Double burden of disease simply means the coexistence of communicable and noncommunicable or chronic diseases. This review discuss the general outline of patterns in communicable and noncommunicable disease transition, i.e. the “epidemiological transition that has occurred and is occurring in developing countries, taking Africa an example. From the Information and data on communicable and chronic diseases available online It is evident that epidemiological transition is gradually creeping in Africa, a coexistence of chronic and degenerative non-communicable diseases with the longstanding prevalence of infectious and communicable diseases in those societies. Africa, the main habitat of disease globally retaining its traditional reputation as harbouring the known communicable diseases, now is increasingly challenged by the package of the known chronic diseases characteristic of Western societies, the so-called “non-communicable diseases” which were almost not known before, are now responsible for 47% of all deaths in that region and are predicted to grow sizeably in the future. Besides malaria, Shistosoma, tuberculosis, haemorrhagic fevers, eye infections, childhood infections and HIV/AIDS, diseases of development and modernization of mostly non-communicable origin such as coronary artery disease, atherosclerosis and obesity are now topping the list disease ranking. Rural-urban migration, urbanization, overcrowding of African cities, adoption of western patterns of lifestyles or the “coca-colonization”, dietary and lifestyle change, exercise reduction, epidemic rates of tobacco & alcohol consumption, increased environmental pollution and allergen challenges, violence, psychiatric problems, are thought responsible. To conclude, the double burden of communicable and chronic diseases presents complex medical, psychosocial, economic and political challenges in Africa, these challenges undermine the development of effective and sustainable primary and secondary interventions, and a step-wise road map approach is suggested for such interventions.

Key words: Double-Burden of Disease, Epidemiological Transmission, Communicable Diseases, Non- Communicable Diseases NCDs, Global Burden of Disease Studies GBDS

Similar Articles

BLOOD PARASITE INFECTIONS IN STRIGIFORMES AND PSITTACIFORMES SPECIES IN CAPTIVITY WITH A NEW RECORD OF POTENTIAL FATAL BLOOD PARASITE TRANSMISSION TO PARROTS.
García-Del-Río M, Sancho R, Martínez J, Merino S
Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Vete. 2021; 51(4): 799-813

Development of 'multiresistance rice' by an assembly of herbicide, insect and disease resistance genes with a transgene stacking system.
Li C, Zhang J, Ren Z, Xie R, Yin C, Ma W, Zhou F, Chen H, Lin Y
Pest management science. 2021; 77(3): 1536-1547

Leaf spot disease of Orychophragmus violaceus caused by Alternaria tenuissima in China.
Liu D, Li J, Zhang S, Wang X, Xiang W, Zhang J
Plant disease. 2021; ():

Advancing UK Regulatory Science Strategy in the Context of Global Regulation: a Stakeholder Survey.
Cruz Rivera S, Torlinska B, Marston E, Denniston AK, Oliver K, Hoare S, Calvert MJ
Therapeutic innovation & regulatory science. 2021; ():

DAMPs as Double-edged Swords in Sepsis.
Zhou M, Aziz M, Wang P
Antioxidants & redox signaling. 2021; ():

Poisonous medicinal plants used in the popular pharmacopoeia of the Rif, northern Morocco.
Chaachouay N, Benkhnigue O, Douira A, Zidane L
Toxicon : official journal of the International Society on Toxinology. 2021; 189(): 24-32

Determination of Main Bitter Compounds in Soaked and Germinated Sesame Pastes.
Hou L, Zhang Y, Li C, Wang X, Wang SC
Journal of oleo science. 2021; 70(1): 31-38

Analytical evaluation of serum non-transferrin-bound iron and its relationships with oxidative stress and cardiac load in the general population.
Sugiura T, Dohi Y, Takase H, Fujii S, Seo Y, Ohte N
Medicine. 2021; 100(7): e24722